Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03363113
Other study ID # CE_20150630_7_LSM
Secondary ID
Status Completed
Phase N/A
First received November 30, 2017
Last updated November 30, 2017
Start date January 1, 2016
Est. completion date July 12, 2016

Study information

Verified date November 2017
Source Fondation Ophtalmologique Adolphe de Rothschild
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Symptoms of oromandibular dystonia can be alleviated by injections of botulinum toxin. The scope of this study is to describe the efficacy of this procedure, by a retrospective systematic review of patients medical charts


Recruitment information / eligibility

Status Completed
Enrollment 240
Est. completion date July 12, 2016
Est. primary completion date April 1, 2016
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria:

- Patient suffering from oromandibular dystonia

- Medical follow up in the Fondation Ophtalmologique Rothschild (Paris)

- Treatment by at least one session of botulinum toxin injection

Exclusion Criteria:

- Patient cannot assess symptoms improvement using a Likert scale

Study Design


Related Conditions & MeSH terms


Intervention

Drug:
Botulinum Toxins
Injection of botulinum toxin in the muscles affected by oromandibular dystonia

Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
Fondation Ophtalmologique Adolphe de Rothschild

Outcome

Type Measure Description Time frame Safety issue
Primary Clinical improvement score Likert scale for the assessment of the clinical improvement after treatment Two months
See also
  Status Clinical Trial Phase
Recruiting NCT03428009 - Dystonia Genotype-Phenotype Correlation